Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- Sepelvaltimokierto (2024) Kardiologia Kiviniemi, Tuomas; Sinisalo, Juha
- Temporal Relation Between Myocardial Infarction and New-Onset Atrial Fibrillation: Results from a Nationwide Registry Study (2024)
- American Journal of Cardiology
- The Role of MAPRE2 and Microtubules in Maintaining Normal Ventricular Conduction (2024)
- Circulation Research
- Transcriptomic and spatial dissection of human ex vivo right atrial tissue reveals proinflammatory microvascular changes in ischemic heart disease (2024)
- Cell Reports Medicine
- Vascular disease and ischemic stroke in patients with atrial fibrillation: Temporal trends and age-related differences (2024)
- Atherosclerosis
- Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement (2023)
- American Journal of Cardiology
- EKG-tapaus (2023)
- Sydänääni: Suomen Kardiologisen Seuran Lehti
- Risk of fluid accumulation after cardiac surgery (2023)
- JTCVS Open
- Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism (2022)
- European Heart Journal - Quality of Care and Clinical Outcomes
- Disadvantages of high fluid infusion rate in cardiac surgery (2022)
- European Journal of Anaesthesiology
- EKG-tapaus (2022)
- Sydänääni: Suomen Kardiologisen Seuran Lehti
- End-to-end sensor fusion and classification of atrial fibrillation using deep neural networks and smartphone mechanocardiography (2022)
- Physiological Measurement
- Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study (2022)
- Annals of Medicine
- Late incidence and recurrence of new-onset atrial fibrillation after isolated surgical aortic valve replacement (2022)
- Journal of Thoracic and Cardiovascular Surgery
- Mechanocardiography-Based Measurement System Indicating Changes in Heart Failure Patients during Hospital Admission and Discharge (2022)
- Sensors
- Mechanocardiography in the Detection of Acute ST Elevation Myocardial Infarction: The MECHANO-STEMI Study (2022)
- Sensors
- Polygenic Risk Scores for Predicting Adverse Outcomes After Coronary Revascularization (2022)
- American Journal of Cardiology
- Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study (2021)
- Annals of Medicine
- Anticoagulation Therapy After Biologic Aortic Valve Replacement (2021)
- Frontiers in Cardiovascular Medicine
- A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery--LAA-CLOSURE trial protocol (2021)
- American Heart Journal



